** UnitedHealth Group UNH.N reported fourth-quarter profit on Thursday that beat analysts' estimates
** However, UNH posted annual medical care ratio - percentage of premiums spent on medical care - of 85.5%, compared to expectation of 84.96%
MEDICAL COSTS A CONCERN
** BofA Global Research ("buy," PT: $675) says UNH has strong position vs Medicare Advantage peers; sees more potential for MLR recovery in 2026
** Oppenheimer ("outperform," PT: $640) says UNH's stock performance should improve, but rising medical costs could be a hurdle
** Leerink Partners ("outperform," PT: $675) says, "our thesis remains anchored to diminishing controversies with accelerating growth and margin expansion into 2026 against a less bad Medical Advantage backdrop"
** RBC ("outperform," PT: $655) says cost trend increase is largely one-time, while outlook for healthcare service utilization is stabilizing
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.